Navigation Links
Some older ER patients are getting the wrong medicines, U-M study finds
Date:3/12/2010

ANN ARBOR, Mich. A University of Michigan study recently published in Academic Emergency Medicine says that it is common for patients 65 and older to receive potentially inappropriate medications when treated in an emergency room.

Nearly 19.5 million older patients, or 16.8 percent of eligible emergency visits from 2000-2006, received one or more potentially inappropriate medications or PIMs. The large sample of approximately 470,000 ED and outpatient clinic visits, corresponding to a national estimate of about 1.5 billion total visits, allowed the researchers to determine the extent of the problem nationwide.

"There are certain medications that probably are not good to give to older adults because the potential benefits are outweighed by potential problems," says lead author, William J. Meurer, M.D., M.S., assistant professor, U-M Departments of Emergency Medicine and Neurology.

Researchers looked at a nationwide sample of emergency visits using data from the National Hospital Ambulatory Medical Care Survey, to see how many patients aged 65 and older sent home from the ED were prescribed potentially inappropriate medications.

Ten medications accounted for 86.5 percent of PIMs used in the ED. The five most common ones were promethazine, ketorolac, propoxyphene, meperidine, and diphenhydramine; and two of these promethazine and ketorolac accounted for nearly 40%.

Meurer suggested that further efforts are needed to educate doctors about the suitability of certain medications for older adults.

He also says the study showed that prescribing inappropriate medications was less likely to occur if a resident or intern was involved in the treatment, probably due to the fact that younger doctors have had recent training about medications.

There was substantial regional and hospital type (teaching vs. non-teaching) variability. PIMs were less likely to occur in visits to hospitals in the Northeast and twice as likely in other parts of the country. And receiving a potentially inappropriate medication was more likely to occur at for-profit hospitals.

The study did not explore the possibility of medication interactions, so it is possible that the potential harm by medications is underestimated.

Meurer offers the following advice to patients:

  • Make sure you talk to your primary care physician, either during or after your ED visit.
  • Know what medications and supplements you are taking and make sure the nurses and doctors at the ED know.
  • Talk to the ED doctors and nurses about how long the medicines they have given you will affect you.
  • Ask for a list of all medications that you received while at the ED before you leave the ED for home or to go to a bed in the hospital. The list should include information on the possible side effects of those medicines.
  • If you leave the ED and then have an adverse event caused by medication, contact your physician immediately or go back to the emergency department.
  • Be proactive with your pharmacy and make sure you understand what you are taking.


'/>"/>

Contact: Bruce Spiher
spiher@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related medicine news :

1. Ability to cope with stress can increase good cholesterol in older white men, study finds
2. Many Older Americans Have Active Sex Lives
3. Good Cholesterol Wont Help Heavy-Drinking Older Men
4. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. Frequent alcohol consumption increases cancer risk in older women
7. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
8. ISS and Glass Lewis Recommend Cholestech Stockholders Vote FOR Merger
9. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
10. Drug-free treatments offer hope for older people in pain
11. United Medicorp, Inc.s Shareholders Approve All Proposals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: